Nanjing Norman Can Produce 3 Million Doses of Novel Coronavirus (PEI) Reagents Per Day Facing the repeated ravages of COVID-19 in Europe, rapid antigen detection, as a fast and convenient novel coronavirus detection method, has been one of the main methods used by many countries and organizations for the test of early infected people. Following the admittance of self-testing in German, in order to encourage everyone to do self-testing twice a week, the British government will introduce the plan of free self-testing for all citizens formally. Therefore, everyone in England will receive the twice-weekly rapid test of COVID-19. This is a huge expansion of the government’s massive asymptomatic testing plan. Then the European countries will encourage self-testing one by one, resulting to concentration outbreak of market needs. Countless orders hit those Chinese companies which have obtained PEI. While Chinese IVD companies are bothering about their poor production capacity of Colloidal gold. Most of them just have small scale of clean area factory, less than 500 square meters. Only a few large-sized enterprises like Nanjing Norman have daily capacity of million doses. To ensure over 100 million people per month’s production capacity, first, the upstream raw materials should be sufficient; second, the production GMP workshop must be at least 3000 square meters and equipped with fully automatic assembly lines; finally, government’s support to ensure enough production workers. Nanjing Norman Biological Technology Co., LTD., founded in 2008, is one of the leading enterprises in the field of Automatic chemiluminescence in China. It is the company with the fastest development of POCT rapid diagnostic reagents, one of the few domestic in vitro diagnostic industry that has both antigens, antibodies, and reagents, and one of the enterprises with the ability of R&D, production and sales of products such as, instruments and so on. Its advantages lie in its strong R&D capabilities, self-produced raw materials, and national using certificate of testing mouse. The factory area of the company is 31,000 square meters with four floors of 100,000-grade GMP clean production area. Norman have a strong quality control system from raw material, such as automatic inner packaging material cleaning line, automatic film sticking machine, automatic scribing machine, automatic gold spraying instrument and so on, to ensure the timeliness of shipment with fully automated production. Professional version has been completely exported to Germany, Czech Republic, Holland, France and other medical institutions. Norman Also will obtain the BfArM self-testing certificate in the coming future, then the approval will be added to the self-testing list. Novel Coronavirus (2019-nCoV) Antigen Testing Kit has previously obtained EU CE certification (for professional use), and can be sold in EU countries and countries that recognize EU CE certification. Chuzhou City of Anhui Province is ...

CHONGQING CACLP 2021 NORMAN N1-T001 We are going to do better in 2021 !

The Norman IgG / IgM antibody detection reagent was officially registered in South Africa through local clinical trials and was successfully registered with the Ministry of Health and was approved for legal use in the South African market.

Norman Novel Coronavirus (2019-nCoV) Antigen Testing Kit (Colloidal Gold) is officially listed in the German Drug Administration(BfArm)'s recommended purchase list of covid-19 reagents! For more product info, you could visit: https://www.normanbio.com/novel-coronavirus-2019-ncov-antigen-testing-kit-colloidal-gold_p8.html

2020 was a special year. It’s been a year of ups and downs, It’s also a year of love and hope. Review this year, Norman renewed history again and again, Achieved breakthroughs, Amidst difficulties and setbacks, Norman was searching solutions Amidst flowers and applause, Norman has gained persistence and affirmation... On the first day of 2020, let's look back to Norman's extraordinary year—— January Dedicated to “anti-epidemic”, and has been listed as a key enterprise of Jiangsu Province for the prevention and control of 2019-nCoV At the beginning of the virus outbreak, Norman took the initiative to assume the social responsibilities by quickly establishing a special team to make voluntary donations for the epidemic area. meanwhile urgently engage in work from the Spring Festival holiday,deploying all the engineers to stand by at every time to ensure the normal use of hospital instruments. At the same time, Norman R&D team started the research and development of 2019-nCoV rapid test kit to provide necessary aid for the front-line clinical medical workers. During the epidemic, Norman has donated  more than 15 million yuan in medical testing equipment and reagents for epidemic area. Norman staff  have always been the strong backing of the national medical workers, fighting together with them to the final victory. February Obtained the “Experimental Animal License” from Science and Technology Department of Jiangsu Province,and established and experimental animal center: Built a 472㎡ SPF-class animal laboratory.The establishment of this center has realized the self-production of important raw materials--antigen and antibody, providing more efficient and reliable support for the quality of our products. April Export white list from ministry of commerce has been achieved for 2019-nCov Antibody test kit. Two consecutive years won the honor of municipal“Gazelle Enterprise” . Retaining his honor is  the badge of Norman’s innovation and growth rate.Norman will engage in and create new impetus  to accelerate Nanjing in building “Innovative City”. June Won the title of ”Nanjing Intellectual Property Demonstration Enterprise”,with more than hundreds of Intellectual property potent. (PATENT WALL) July Procalcitonin (PCT) antibody was authorized by EU patent (Patent No.: 16820699.3) Norman became the second company in the world to hold this invention patent after B·R·A·H·M·S. October Introduced strategic investment and improved shareholder structure. Novel Coronavirus Antigen test kit Obtained White List Certification by the Medical Insurance Chamber of Commerce. November Entered the list of "Lingque Enterprise". Norman is recognized as an innovative small and medium-sized enterprise with high growth potential and capable of driving regional economic devel...

EQA is a evaluation process committed for qualifying the eligibility of laboratories in running test conducted by external independent institute which is competent for the collection and audition of test results of laboratories. In June, NCCL (National Center for Clinical Laboratories) announce the China’s EQA manifested statistics concerning cardiovascular marker,PCT and NT PRO-BNP. As a single subgroup acompanied by other our 50+ end clients (hospital) has been approved to pass the criteria in full scores which merits a verdict that norman has kept its continuous improvement in clinical diagnostic spectrum.

In early summer, Norman has once again retain the good news ! After rigorous product testing and verification in the early stage, the company entered the 47th in the export whitelist of the Ministry of Commerce in China on May 11, 2020! The 2019nCoV is still raging around the world. Norman obtained the EU CE certification in time to realize the free circulation of products within the EU member states. It can quickly deliver materials to fight against the epidemic to European countries and help local health organizations get over this global epidemic . I believe that with the efforts of people from all spectrum of society in various country, the epidemic will be effectively controlled and the final victory will be achieved!